CN Patent

CN103108863A — 低醚杂质的阿托伐他汀的制备

Assigned to Centrient Pharmaceuticals Netherlands BV · Expires 2013-05-15 · 13y expired

What this patent protects

本发明涉及一种通过浓缩步骤的方式来制备杂质(3)和(4)的水平降低的阿托伐他汀的方法。

USPTO Abstract

本发明涉及一种通过浓缩步骤的方式来制备杂质(3)和(4)的水平降低的阿托伐他汀的方法。

Drugs covered by this patent

pitavastatin-magnesium (PITAVASTATIN MAGNESIUM)

Patent Metadata

Patent number: CN103108863A
Jurisdiction: CN
Classification: —
Expires: 2013-05-15
Drug substance claim: No
Drug product claim: No
Assignee: Centrient Pharmaceuticals Netherlands BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.